Filing Details
- Accession Number:
- 0001104659-16-139269
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-12 13:01:53
- Reporting Period:
- 2016-08-10
- Filing Date:
- 2016-08-12
- Accepted Time:
- 2016-08-12 13:01:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1638287 | Gemphire Therapeutics Inc. | GEMP | Pharmaceutical Preparations (2834) | 472389984 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1674006 | Mina Sooch | 43334 Seven Mile Road Suite 1000 Northville MI 48167 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-08-10 | 11,078 | $0.00 | 11,078 | No | 4 | C | Indirect | Held by the Arvinder S. Sooch Trust |
Common Stock | Acquisiton | 2016-08-10 | 1,212 | $6.71 | 12,290 | No | 4 | J | Indirect | Held by the Arvinder S. Sooch Trust |
Common Stock | Acquisiton | 2016-08-10 | 27,141 | $6.71 | 39,431 | No | 4 | C | Indirect | Held by the Arvinder S. Sooch Trust |
Common Stock | Acquisiton | 2016-08-10 | 52,500 | $10.00 | 693,732 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | Held by the Arvinder S. Sooch Trust |
No | 4 | J | Indirect | Held by the Arvinder S. Sooch Trust |
No | 4 | C | Indirect | Held by the Arvinder S. Sooch Trust |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Convertible Preferred Stock | Disposition | 2016-08-10 | 11,078 | $0.00 | 11,078 | $0.00 |
Common Stock | 8% Convertible Subordinated Promissory Notes | Disposition | 2016-08-10 | 0 | $0.00 | 27,141 | $6.71 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- The Series A Convertible Preferred Stock converted into shares of common stock, par value $0.001 per share (the "Common Stock"), of Gemphire Therapeutics Inc. (the "Company") on a one-for-one basis immediately prior to the closing of the Company's initial public offering and had no expiration date.
- Arvinder Sooch is the reporting person's husband. These shares are indirectly owned by him as trustee of the Arvinder S. Sooch Trust.
- Represents shares of Common Stock issued for payment of accrued dividends on the Series A Convertible Preferred Stock.
- The notes were issued in the original principal amount of $175,000. The outstanding principal and $7,015 of accrued interest on the notes automatically converted into shares of Common Stock immediately prior to the closing of the Company's initial public offering.